The American College of Rheumatology’s (ACR) 2014 Annual Meeting will be held at the Boston Convention and Exhibition Center from Friday, November 14 to Wednesday, November 19 in Boston, Massachusetts. The ACR Annual Meeting is rheumatology’s premier scientific meeting for those involved in research or delivery of rheumatologic care or services.
The event is an opportunity for rheumatology experts from around the world to gather in one place to discuss the latest innovations in prevention, diagnosis, and treatment of rheumatic diseases. There will also be presentations on the latest discoveries and research that are transforming rheumatic disease care.
The ACR Annual Meeting program outlines the following global learning objectives: Continue reading
Image courtesy of hywards at FreeDigitalPhotos.net
Have you recently been recommended to take BIOLOGIC medications for Rheumatoid Arthritis?
The latest online tool to help make your treatment decisions.
We are looking for people with rheumatoid arthritis to test a new online tool that helps to make decisions about using biologic medications.
If you have been recommended to consider using a biologic by your doctor but have not started yet, we invite you to participate in this study.
You may be eligible if you:
- Have rheumatoid arthritis
- See a rheumatologist
- Have received a recommendation to consider biologic therapy
- Have a valid email and internet access
The study will take about two hours to complete over a span of four to six weeks, and can be completed remotely. Any information you provide will be completely confidential. An honorarium will be provided for your time.
If you would like more information, please contact Jasmina Memetovic, Research Coordinator by phone at 604-207-4007, toll free 1-877-871-4575, or email email@example.com.
Ms. Catherine Hofstetter is the inaugural recipient of the 2014 Qualman-Davies Arthritis Consumer Community Leadership Award.
A successful business owner living with rheumatoid arthritis, Cathy has been an arthritis advocate for seventeen years championing the patient experience, promoting more effective treatments and healthcare policies, and motivating and mentoring consumers to become involved in research decision-making and positive reform of the healthcare system.
Fighting disease is one of the longest, toughest battles in the world. But the rewards of scientific breakthroughs are great – often revolutionary – leading to diagnosis, treatment and cure. The Canada Gairdner Awards celebrate and reward the scientists who make these discoveries.
Great research has no borders. The Gairdners …Canada’s only major international scientific prize, inspire medical research, present and future. They are ours, but they belong to the world.
— Globe and Mail, Editorial October 2009
The Arthritis Alliance of Canada is happy to announce that two of the recipients of the Canada Gairdner International Award will be presenting “Arthritis Unmasked: Genetics, Treatments and Partnerships” at the Arthritis Alliance of Canada’s 2nd Annual Conference and Research Symposium. Sir Marc Feldmann, FRS FAA, and Sir Ravinder Nath Maini, FRS FMEDSCI FRCP, have been recognized “for the discovery of anti-TNF therapy for the treatment of rheumatoid arthritis and other inflammatory diseases”.
Seven Canada Gairdner Awards are given annually in three different areas. Each award is valued at $100,000 CDN.
The Qualman-Davies Arthritis Consumer Community Leadership Award was created in 2014 to recognize one person’s contributions to helping all Canadians living with the disease to be heard in decision-making processes that affect millions. That’s what Ann Qualman and Jim Davies did as early pioneers in arthritis advocacy in Canada. Their tireless and selfless efforts helped millions of Canadians.
According to the results from the JointHealth™ Program Satisfaction and Interest survey, people living with arthritis want to learn about natural ways to help treat or ease the pain from arthritis, including rheumatoid arthritis (RA). Below are some life hacks for rheumatoid arthritis that you can consider. Please note that this article is for information purposes only and not intended to be medical advice. Talk to your healthcare provider before changing or starting a new treatment plan.